Live Q&A
Time: 1:00 pm
day: Day Two
Details:
Using this opportunity to ask your expert speakers those burning questions.
Speakers:
Claire Langrish is the Vice President, Immunology and Biology, at Principia Biopharma. She is focused on the translation of drug and disease mechanisms, to discover and develop innovative therapies for immune-mediated diseases. During her post-doc at DNAX, Claire identified the key role of IL-23 in autoimmunity, and discovered Th17 cells, resulting in a dramatic shift in the…Read more
Cell & molecular biologist with 15+ years of post-PhD discovery & translational research experience in therapeutic areas of hematology (myeloma, lymphoma), oncology, autoimmune diseases in academia & pharma environments. Initiated mechanism of action–based biomarker development efforts to predict outcome and response to therapy & to better position differentiated products to overcome resistance to current standards of care in hematologic…Read more
Bertrand Huard received his Ph.D. degree in Immunology from the university Paris VII Denis Diderot in 1995. At that time, he discovered the function of a molecule called lymphocyte activation gene 3, an actual immune checkpoint to watch in the immunotherapy of cancers. His first postdoctoral training at the Scripps research institute in San Diego…Read more
